tetano
Editor, Senior Moderator
Am J Med Case Rep
. 2020 Dec;8(12):486-490.
doi: 10.12691/ajmcr-8-12-15. Epub 2020 Sep 15.
Extensive Peripheral Arterial Thrombosis in a Patient with SARS-CoV-2 Infection
Yuvraj S Chowdhury[SUP] 1 [/SUP], Cristina A Mitre[SUP] 2 [/SUP], Vittorio E Rotella[SUP] 3 [/SUP], Karan Garg[SUP] 4 [/SUP], David K Lee[SUP] 5 [/SUP], Pooja Belligund[SUP] 5 [/SUP], Lu Chen[SUP] 2 [/SUP], Paul Madaj[SUP] 1 [/SUP], Haytham A Aboushi[SUP] 6 [/SUP], Mohammad R Al-Ajam[SUP] 5 [/SUP], Samy I McFarlane[SUP] 6 [/SUP]
Affiliations
Abstract
Thrombosis is one of the major underlying pathogenetic mechanisms leading to increased morbidity and mortality among COVID-19 patients. Thromboembolic events as well as severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) are the major causes of death in this continued pandemic. While elevated D-dimer level suggests worse thrombotic outcomes, levels at which benefits of anticoagulation outweigh the bleeding risk is yet to be determined. In this report, we present a case of a 72-year-old man with COVID-19 presented with confusion and subsequently developed acute hypoxic respiratory failure. On hospital day 7, patient developed extensive peripheral arterial thrombosis with acute rise of D-dimer from 800 to 14,899 ng/ml. He was treated with heparin drip and underwent urgent brachial, radial and ulnar embolectomy under general anesthesia. In this report, we also discuss the pathogenetic mechanisms and management of thromboembolism in COVID-19 patients, highlighting the role of early detection and aggressive therapeutic interventions that could be life and / or limb saving strategy.
Keywords: COVID-19; D-dimer; arterial thrombosis; limb ischemia; point-of-care ultrasound.
. 2020 Dec;8(12):486-490.
doi: 10.12691/ajmcr-8-12-15. Epub 2020 Sep 15.
Extensive Peripheral Arterial Thrombosis in a Patient with SARS-CoV-2 Infection
Yuvraj S Chowdhury[SUP] 1 [/SUP], Cristina A Mitre[SUP] 2 [/SUP], Vittorio E Rotella[SUP] 3 [/SUP], Karan Garg[SUP] 4 [/SUP], David K Lee[SUP] 5 [/SUP], Pooja Belligund[SUP] 5 [/SUP], Lu Chen[SUP] 2 [/SUP], Paul Madaj[SUP] 1 [/SUP], Haytham A Aboushi[SUP] 6 [/SUP], Mohammad R Al-Ajam[SUP] 5 [/SUP], Samy I McFarlane[SUP] 6 [/SUP]
Affiliations
- PMID: 33294588
- PMCID: PMC7721088
- DOI: 10.12691/ajmcr-8-12-15
Abstract
Thrombosis is one of the major underlying pathogenetic mechanisms leading to increased morbidity and mortality among COVID-19 patients. Thromboembolic events as well as severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) are the major causes of death in this continued pandemic. While elevated D-dimer level suggests worse thrombotic outcomes, levels at which benefits of anticoagulation outweigh the bleeding risk is yet to be determined. In this report, we present a case of a 72-year-old man with COVID-19 presented with confusion and subsequently developed acute hypoxic respiratory failure. On hospital day 7, patient developed extensive peripheral arterial thrombosis with acute rise of D-dimer from 800 to 14,899 ng/ml. He was treated with heparin drip and underwent urgent brachial, radial and ulnar embolectomy under general anesthesia. In this report, we also discuss the pathogenetic mechanisms and management of thromboembolism in COVID-19 patients, highlighting the role of early detection and aggressive therapeutic interventions that could be life and / or limb saving strategy.
Keywords: COVID-19; D-dimer; arterial thrombosis; limb ischemia; point-of-care ultrasound.